Ontology highlight
ABSTRACT: Objective
We investigated (1) the associations of pre-stroke aspirin use with thrombus burden, infarct volume, hemorrhagic transformation, early neurological deterioration (END), and functional outcome, and (2) whether stroke subtypes modify these associations in first-ever ischemic stroke.Methods
This multicenter magnetic resonance imaging (MRI)-based study included 5,700 consecutive patients with acute first-ever ischemic stroke, who did not undergo intravenous thrombolysis or endovascular thrombectomy, from May 2011 through February 2014. Propensity score-based augmented inverse probability weighting was performed to estimate adjusted effects of pre-stroke aspirin use.Results
The mean age was 67 years (41% women), and 15.9% (n = 907) were taking aspirin before stroke. Pre-stroke aspirin use (vs nonuse) was significantly related to a reduced infarct volume (by 30%), particularly in large artery atherosclerosis stroke (by 45%). In cardioembolic stroke, pre-stroke aspirin use was associated with a ~50% lower incidence of END (adjusted difference = -5.4%, 95% confidence interval [CI] = -8.9 to -1.9). Thus, pre-stroke aspirin use was associated with ~30% higher likelihood of favorable outcome (3-month modified Rankin Scale score < 3), particularly in large artery atherosclerosis stroke and cardioembolic stroke (adjusted difference = 7.2%, 95% CI = 1.8 to 12.5 and adjusted difference = 6.4%, 95% CI = 1.7 to 11.1, respectively). Pre-stroke aspirin use (vs nonuse) was associated with 85% less frequent cerebral thrombus-related susceptibility vessel sign (SVS) in large artery atherosclerosis stroke (adjusted difference = -1.4%, 95% CI = -2.1 to -0.8, p < 0.001) and was associated with ~40% lower SVS volumes, particularly in cardioembolic stroke (adjusted difference = -0.16 cm3 , 95% CI = -0.29 to -0.02, p = 0.03). Moreover, pre-stroke aspirin use was not significantly associated with hemorrhagic transformation (adjusted difference = -1.1%, p = 0.09).Interpretation
Pre-stroke aspirin use associates with improved functional independence in patients with first-ever ischemic large arterial stroke by reducing infarct volume and/or END, likely by decreasing thrombus burden, without increased risk of hemorrhagic transformation. ANN NEUROL 2021;90:763-776.
SUBMITTER: Ryu WS
PROVIDER: S-EPMC9292882 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
Ryu Wi-Sun WS Schellingerhout Dawid D Hong Keun-Sik KS Jeong Sang-Wuk SW Kim Beom Joon BJ Kim Joon-Tae JT Lee Kyung Bok KB Park Tai Hwan TH Park Sang-Soon SS Park Jong-Moo JM Kang Kyusik K Cho Yong-Jin YJ Park Hong-Kyun HK Lee Byung-Chul BC Yu Kyung-Ho KH Oh Mi Sun MS Lee Soo Joo SJ Kim Jae Guk JG Cha Jae-Kwan JK Kim Dae-Hyun DH Lee Jun J Han Moon-Ku MK Park Man Seok MS Choi Kang-Ho KH Nahrendorf Matthias M Lee Juneyoung J Bae Hee-Joon HJ Kim Dong-Eog DE
Annals of neurology 20211005 5
<h4>Objective</h4>We investigated (1) the associations of pre-stroke aspirin use with thrombus burden, infarct volume, hemorrhagic transformation, early neurological deterioration (END), and functional outcome, and (2) whether stroke subtypes modify these associations in first-ever ischemic stroke.<h4>Methods</h4>This multicenter magnetic resonance imaging (MRI)-based study included 5,700 consecutive patients with acute first-ever ischemic stroke, who did not undergo intravenous thrombolysis or ...[more]